Visuoperceptual impairment in dementia with Lewy bodies.

BACKGROUND In dementia with Lewy bodies (DLB), vision-related cognitive and behavioral symptoms are common, and involvement of the occipital visual cortices has been demonstrated in functional neuroimaging studies. OBJECTIVES To delineate visuoperceptual disturbance in patients with DLB in comparison with that in patients with Alzheimer disease and to explore the relationship between visuoperceptual disturbance and the vision-related cognitive and behavioral symptoms. DESIGN Case-control study. SETTING Research-oriented hospital. PATIENTS Twenty-four patients with probable DLB (based on criteria of the Consortium on DLB International Workshop) and 48 patients with probable Alzheimer disease (based on criteria of the National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association) who were matched to those with DLB 2:1 by age, sex, education, and Mini-Mental State Examination score. MAIN OUTCOME MEASURES Four test items to examine visuoperceptual functions, including the object size discrimination, form discrimination, overlapping figure identification, and visual counting tasks. RESULTS Compared with patients with probable Alzheimer disease, patients with probable DLB scored significantly lower on all the visuoperceptive tasks (P<.04 to P<.001). In the DLB group, patients with visual hallucinations (n = 18) scored significantly lower on the overlapping figure identification (P = .01) than those without them (n = 6), and patients with television misidentifications (n = 5) scored significantly lower on the size discrimination (P<.001), form discrimination (P = .01), and visual counting (P = .007) than those without them (n = 19). CONCLUSIONS Visual perception is defective in probable DLB. The defective visual perception plays a role in development of visual hallucinations, delusional misidentifications, visual agnosias, and visuoconstructive disability charcteristic of DLB.

[1]  E. Mori,et al.  Distinctive neurobehavioral features among neurodegenerative dementias. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[2]  K. Ishii,et al.  Regional cerebral blood flow difference between dementia with Lewy bodies and AD , 1999, Neurology.

[3]  K. Ishii,et al.  Visual hallucinations and regional cerebral metabolism in dementia with Lewy bodies (DLB). , 1999, Neuroreport.

[4]  D E Kuhl,et al.  Motor correlates of occipital glucose hypometabolism in Parkinson’s disease without dementia , 1999, Neurology.

[5]  E. Mori,et al.  Cognitive loss in dementia with Lewy bodies and Alzheimer disease. , 1998, Archives of neurology.

[6]  F. Andermann,et al.  Complex visual hallucinations. Clinical and neurobiological insights. , 1998, Brain : a journal of neurology.

[7]  R. Elble,et al.  Hemianopsia in dementia with Lewy bodies. , 1998, Archives of neurology.

[8]  K. Ishii,et al.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease , 1998, Neurology.

[9]  Hiroaki Kazui,et al.  Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease: a comparative study using positron emission tomography , 1997, Neuroscience Letters.

[10]  E. Mori,et al.  The disturbances of object vision and spatial vision in Alzheimer's disease. , 1997, Dementia and geriatric cognitive disorders.

[11]  R. Albin,et al.  Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[12]  M. Sambrook,et al.  Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[13]  Z Walker,et al.  Neuropsychological performance in Lewy body dementia and Alzheimer's disease , 1997, British Journal of Psychiatry.

[14]  Jeffrey L. Cummings,et al.  Dementia with Lewy bodies , 1996, Neurology.

[15]  S. Minoshima,et al.  In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease , 1996, Annals of neurology.

[16]  R. Albin,et al.  Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease , 1996, Neurology.

[17]  D. Salmon,et al.  Clinical and Neuropathological Findings in Lewy Body Dementias , 1996, Brain and Cognition.

[18]  Douglas Galasko,et al.  Neuropsychological Deficits Associated with Diffuse Lewy Body Disease , 1996, Brain and Cognition.

[19]  R. Mohs The Alzheimer's Disease Assessment Scale , 1996, International Psychogeriatrics.

[20]  E. Byrne,et al.  Clock-face drawing to differentiate Lewy body and Alzheimer type dementia syndromes , 1996, The Lancet.

[21]  I. McKeith,et al.  Dementia with Lewy Bodies: Noncognitive symptoms in Lewy body dementia , 1996 .

[22]  D. Brooks,et al.  Dementia with Lewy Bodies: Positron emission tomography findings in Parkinson's disease and Lewy body dementia , 1996 .

[23]  K. Jellinger,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. , 1996, Neurology.

[24]  M. Esiri,et al.  Prospective study of relations between cortical Lewy bodies, poor eyesight, and hallucinations in Alzheimer's disease. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[25]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[26]  K. Davis,et al.  Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease. , 1994, Neuroreport.

[27]  D. Galasko,et al.  Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies , 1993, Neurology.

[28]  A. Burns Clinical diagnosis of Alzheimer's disease , 1991 .

[29]  T. Di Paolo,et al.  Decreased dopamine in the retinas of patients with Parkinson's disease. , 1990, Investigative ophthalmology & visual science.

[30]  I. Bodis-Wollner Visual deficits related to dopamine deficiency in experimental animals and Parkinson's disease patients , 1990, Trends in Neurosciences.

[31]  Robert H. Perry,et al.  Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly , 1990, Journal of the Neurological Sciences.

[32]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[33]  E. Perry,et al.  SENILE DEMENTIA OF LEWY BODY TYPE AND SPECTRUM OF LEWY BODY DISEASE , 1989, The Lancet.

[34]  C. Bulens,et al.  Effect of levodopa treatment on contrast sensitivity in Parkinson's disease , 1987, Annals of neurology.

[35]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[36]  K. Davis,et al.  The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. , 1983, Psychopharmacology bulletin.

[37]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[38]  R. Adams,et al.  Principles of Neurology , 1996 .

[39]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[40]  D. Wechsler Manual for the Wechsler Adult Intelligence Scale. , 1955 .